Report Company Directory

Cosan S.A.

• LatAm Oil & Gas "LightHouse: PBR (2x), BRKM, CSAN, RAIZ (2x), Fuel Dist.,..." by UBS AG
• LatAm Oil & Gas "LightHouse: BRAV (2x), PRIO, VBBR, BRKM, Petchems, Global..." by UBS AG
• LatAm Oil & Gas "LightHouse: YPF, PRIO, UGPA, Fuel Dist., Agri. (3x),..." by UBS AG
• LatAm Oil & Gas "LightHouse: EC, BRAV, CSAN, RAIZ, Fuel Dist., Agri. (2x),..." by UBS AG
• LatAm Oil & Gas "LightHouse: PBR, UGPA, BRKM, CSAN (2x), RAIZ, Fuel Dist...." by UBS AG
• LatAm Oil & Agri Weekly Monitor "The Navigator - Argentina in the..." by UBS AG
• LatAm Oil & Gas "LightHouse: PBR, EC, YPF, PRIO, TTEN, Fuel Dist. (2x),..." by UBS AG
• LatAm Oil & Gas "LightHouse: EC, YPF (3x), TTEN, Fuel Dist., Agri. (3x),..." by UBS AG
• LatAm Oil & Gas "LightHouse: PBR, RAIZ, SLCE, Fuel Dist. (2x), Agri. (2x),..." by UBS AG
• LatAm Oil & Agri Weekly Monitor "The Navigator – Commodities setting the..." by UBS AG

COSBOARD INDUSTRIES LTD

COSCIENS BIOPHARMA INC

• COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore by GlobeNewsWire
• COSCIENS Biopharma Inc. Announces Leadership Change by GlobeNewsWire
• COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update by GlobeNewsWire
• COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update by GlobeNewsWire
• COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders by GlobeNewsWire
• COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders by GlobeNewsWire
• COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders by GlobeNewsWire
• COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update by GlobeNewsWire
• COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer by GlobeNewsWire
• COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update by GlobeNewsWire

COSCO (India)

• Six Directors sold 27,000 shares at between 295.500INR and 296.167INR. by SmartInsider
• Ford Equity International Rating and Forecast Report by Ford Equity Research

Cosco Capital

• Cosco Capital Inc: 1 director bought by SmartInsider
• Ford Equity International Rating and Forecast Report by Ford Equity Research